Skip to content
Community, Medical Health Aged Care

Hepatitis NSW supports World Liver Day with launch of new website highlighting liver health

Hepatitis NSW 2 mins read

Hepatitis NSW has joined the worldwide movement to celebrate World Liver Day on Friday, 19 April 2024.

World Liver Day aims to raise awareness about the importance of liver health. The liver is one of the most important organs in your body and is also one of the largest. The liver is an essential organ that performs over 500 functions, in doing so it supports the stomach, the heart and the blood. Specifically, it cleans blood, breaks down food, stores energy and vitamins, sends energy and vitamins to the parts of the body where it is all needed, clots the blood, and stops infections. We literally can’t live without it.

Liver cancer is the seventh most common cause of cancer-related death in Australia and rates are increasing.

Hepatitis CEO Steven Drew said, “The condition is not well understood, with few symptoms many people are not diagnosed until it’s too late. What is known is that both hepatis B and hepatitis C, if left untreated, can quietly damage the liver. As NSW’s leading hepatitis and liver health community organisation, we are committed to helping people look after their liver.

“The good news is that, if diagnosed early, liver disease is treatable, and liver cancer can be prevented. Taking care of one’s liver is crucial to maintaining overall health and preventing liver diseases like hepatitis, cirrhosis, and liver cancer. Public awareness and ready access to easy-to-understand information about liver health is key,” said Mr Drew.

To mark World Liver Day, Hepatitis NSW is launching our refreshed and redesigned website with a special event at NSW Parliament House. The event includes addresses by Hepatitis NSW lived experience speaker Rachel, and leading consultant Gastroenterologist and Hepatologist Dr Joe Lawler. The website will be officially launched by Dr Kerry Chant, the NSW Chief Health Officer.

The revamped Hepatitis NSW website has an expanded liver health section, that covers topics including the causes of liver damage and disease, signs and symptoms, the effects of alcohol and diet on overall liver health, and on liver scarring (cirrhosis). The site also has liver resources available for viewing online, downloading and/or ordering. Importantly, the website also has a searchable service directory that can assist visitors to find appropriate local services across NSW.

Mr Drew said, “The redesigned website is the result of detailed analyses to help identify and define keywords, themes, issues, or blockers and collected feedback. As a result, it offers easier navigation and has a more effective and functional search capability. Most journeys will now take less steps and information will be found more quickly and easily. It has improved legibility based on best practice standards for usability and accessibility, including across a range of devices.”

“I encourage everyone to visit our new, fresh website [ hep.org.au ] and, in particular on World Liver Day, the Liver Health pages  [ hep.org.au/liver-health ]” Said Mr Drew.

“You can also get more information and assistance via our website live chat or by calling the free Hepatitis NSW Infoline (1800 803 990).”


About us:

Hepatitis NSW is a not-for-profit charity started by the hepatitis community. Together we inform, support and educate.


Contact details:

For more information, please contact:

Hepatitis NSW
Steven Drew, CEO
sdrew@hep.org.au
0402 518 285

More from this category

  • Medical Health Aged Care
  • 13/09/2024
  • 12:40
Zenas BioPharma

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading…

  • Medical Health Aged Care
  • 13/09/2024
  • 12:31
Dementia Australia

New report reinforces dementia as chronic disease of 21st century

Updates to the Dementia in Australia report, released today by the Australian Institute of Health and Welfare (AIHW), reinforce that dementia is an urgent public health issue. Dementia is the second leading cause of death in Australia, the leading cause of death of women, the second leading cause of disease burden overall, and the leading cause of burden for people aged 65 and over. Dementia Australia CEO Professor Tanya Buchanan saidthe report highlights the enormity and impact of dementia in Australia as the chronic disease of the 21st century. “Despite the growing number of Australians diagnosed with dementia – there…

  • Medical Health Aged Care, Science
  • 13/09/2024
  • 11:08
La Trobe University

Centre to play key role in global AI medical research

Artificial intelligence promises to unlock new cures for cancer and other diseases by revolutionising the speed, cost and availability of personally designed drugs and enabling these to be tested on “digital twins" before being given to patients. AI will enable broad-spectrum like chemotherapy to be replaced by these more personalised, better targeted treatments. Scientists at La Trobe University's new Australian Centre for Artificial Intelligence in Medical Innovation (ACAMI), launched today, will also apply AI techniques to mRNA therapy development to enable faster design of more precise and effective treatments. Vice-Chancellor Professor Theo Farrell said ACAMI would sit within La Trobe’s…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.